Hints and tips:
...Financial markets closed Germany: GfK consumer climate survey Italy: Liberation Day holiday....
...At other key moments, Holmes appeared anxious discussing documents that she personally altered to include the logos of the pharmaceutical companies Pfizer and Schering-Plough without their permission....
...Mr Hudson, 51, has spent his 28-year career with pharma companies including Schering-Plough, AstraZeneca and Novartis, in the US, Japan and Europe....
...They include a mix of healthcare, consumer staples and tech: GlaxoSmithKline, Roche, ASML, Nestlé, Novartis, Novo Nordisk, L’Oréal, LVMH, AstraZeneca, SAP and Sanofi....
...A V-shaped recovery in kneecaps isn’t in the price, they say....
...A decade ago, the US pharmaceuticals company Merck paid $41bn to acquire Schering-Plough, consolidating and cutting thousands of jobs amid an industry crisis of innovation and confidence....
...Smart reads David v Goliath Large consumer goods companies are starting to feel the impact of their smaller, more innovative rivals....
...(NAR) The day ahead VW v myRight German consumer rights group myRight is expected to be defeated in its first case seeking compensation from Volkswagen over its emissions scandal....
...Novartis, the Swiss drugmaker, last week reported strong demand in Europe for a new drug that has shown the potential to cut hospitalisation rates from heart failure by a fifth....
...US court told PwC cut corners in Colonial audit Control+C, Control+V....
...However, a Pfizer-Allergan tie-up, would be the first full-scale combination between two top-20 pharma groups since Pfizer bought Wyeth and Merck acquired Schering-Plough in 2009....
...GSK last month also moved to strengthen its position in the sector, by agreeing to acquire the consumer healthcare division of Novartis of Switzerland as part of a $20bn asset swap....
...was the norm at the start of this century, from the merger that created GlaxoSmithKline in 2000 and the $67bn purchase of Aventis by Sanofi in 2004, to Pfizer’s $68bn paid for Wyeth, Merck’s $41bn for Schering-Plough...
...Such bets are not always doomed: Novartis did well by buying Alcon eyecare from Nestlé on a 23 times forward multiple. But investors should pause for thought....
...In pharmaceuticals, Fred Hassan received $189m when Schering Plough was bought by Merck, and Hank McKinnell got $188m when he left Pfizer, despite an investor campaign under the slogan “give it back, Hank...
...Unilever, the consumer goods group, and Novartis, the pharmaceutical group, are among those involved....
...In the previous decade, companies tended to fill holes in sales through large acquisitions, such as Merck’s $41bn purchase of Schering-Plough, and Pfizer’s of Wyeth in 2009 for $68bn....
...Ms Jung, who was chief executive from 2001 until April, will be replaced as chairman by Fred Hassan, a current board member and former chief executive of Schering-Plough, the pharmaceutical group that merged...
...The Genentech deal, combined with the “megamergers” in the same year of Pfizer’s $68bn purchase of Wyeth and Merck’s of Schering-Plough for $41bn, was a recent high water mark in dealmaking in the healthcare...
...It also cut prices of two other drugs, its generic versions of AstraZeneca’s lung cancer drug Iressa and Schering-Plough’s brain tumour drug temozolomide....
...pharmaceutical companies, which had jointly run Merial since 1997, and announced their intention in March last year to recombine their assets to include products acquired by Merck after its acquisition of Schering-Plough...
...In a deal that ends arbitration triggered by Merck’s $41bn takeover of Schering-Plough in 2009, the company has scaled back its control over Remicade and Simponi, the reformulated self-injected version....
...The $1m penalty ties with a 2003 settlement by Schering-Plough as the biggest levied by the SEC for a Regulation FD violation since the rules were imposed in 2000....
...J&J said arbitration hearings in a dispute over its rheumatoid arthritis drug Remicade triggered by Merck’s takeover of its partner Schering Plough last year had already been completed, and a decision could...
...FT Alphaville notes shares were trading 33 per cent higher on Wednesday as expectations that a possible counterbid could emerge from either US drug company Merck or consumer goods firm Schering Plough, also...
International Edition